[Federal Register: January 27, 2009 (Volume 74, Number 16)]
[Notices]
[Page 4752]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27ja09-34]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-144]
Notice of Request for Public To Submit Comments; Extension of
Comment Period
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Extension of public comment period.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announced the availability of a draft document available for public
comment entitled ``NIOSH Criteria Document Update: Occupational
Exposure to Hexavalent Chromium'' on October 17, 2008, as well as a
public meeting to be held on January 22, 2009. The document and
instructions for submitting comments can be found at http://
www.cdc.gov/niosh/review/public/144/. Comments were to be provided to
the NIOSH docket by January 31, 2009, as well as given orally at the
public meeting. A request has been received to extend the comment
period to permit the public more time to gather and submit information.
Accordingly, NIOSH is extending the public comment period by 60
days to March 31, 2009.
DATES: Written comments to NIOSH must be sent or postmarked by March
31, 2009. The public meeting will still take place on January 22, 2009,
at Robert A. Taft Laboratories, Taft Auditorium, NIOSH, CDC, 4676
Columbia Parkway, Cincinnati, OH 45226-1998.
Status: The public meeting will include scientists and
representatives from various government agencies, industry, labor, and
other stakeholders, and is open to the public, limited only by the
space available. The meeting room accommodates 80 people. Persons
wanting to attend or provide oral comments at the meeting were
requested to notify the NIOSH Docket Office no later than January 7,
2009, at (513) 533-8611 or by e-mail at nioshdocket@cdc.gov.
Persons wanting to provide oral comments will be permitted up to 20
minutes. If additional time becomes available, presenters will be
notified. Oral comments given at the meeting must also be submitted to
the docket in writing in order to be considered by the Agency. Written
comments will also be accepted at the meeting. Written comments may
also be submitted to the NIOSH Docket Office, Robert A. Taft
Laboratories, 4676 Columbia Parkway, MS-C34, Cincinnati, Ohio 45226,
telephone (513) 533-8611. All material submitted to the Agency should
reference docket number NIOSH-144 and must be submitted by March 31,
2009, to be considered by the Agency. All electronic comments should be
formatted as Microsoft Word. Please make reference to docket number
NIOSH-144.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, Room 111, 4676 Columbia Parkway, Cincinnati, Ohio 45226.
Contact Persons For Technical Information: Kathleen MacMahon, DVM;
(513) 533-8547; MS-C32, Robert A. Taft Laboratories, 4676 Columbia
Parkway, Cincinnati, OH, 45226-1998.
Dated: January 16, 2009.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E9-1694 Filed 1-26-09; 8:45 am]
BILLING CODE 4163-18-P